Diabetes News Roundup: October 2018

Slideshow

Highlights include: "Artificial pancreas" improves glucose control; T1DM often misdiagnosed as T2DM; and a genetic connection for “type 1.5 diabetes.” 

Related Videos
Erin Michos, MD | Credit: Johns Hopkins University
Natalie McCormick, PhD | Credit: American College of Rheumatology
Medha Munshi, MD, (Courtesy: Harvard Health)
David Maahs, MD, PhD
Related Content

SGLT2 Inhibitors Did Not Increase Fracture Risk in Postmenopausal Patients with T2D

September 29th 2023

Untapped Potentials: Exploring Overlooked Therapies for Type 2 Diabetes

September 29th 2023

Pharmacist-Led Interventions Can Improve HbA1c in Underserved Communities

September 29th 2023

Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric

July 6th 2023

Study Identifies Successful Strategies for Improving Diabetes Care Delivery

September 26th 2023

Tirzepatide Bests Semaglutide For A1c, Weight Loss in Indirect Comparison of Clinical Trial Data

September 25th 2023

SGLT2 Inhibitors Did Not Increase Fracture Risk in Postmenopausal Patients with T2D

September 29th 2023

Untapped Potentials: Exploring Overlooked Therapies for Type 2 Diabetes

September 29th 2023

Pharmacist-Led Interventions Can Improve HbA1c in Underserved Communities

September 29th 2023

Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric

July 6th 2023

Study Identifies Successful Strategies for Improving Diabetes Care Delivery

September 26th 2023

Tirzepatide Bests Semaglutide For A1c, Weight Loss in Indirect Comparison of Clinical Trial Data

September 25th 2023

SGLT2 Inhibitors Did Not Increase Fracture Risk in Postmenopausal Patients with T2D

September 29th 2023

Untapped Potentials: Exploring Overlooked Therapies for Type 2 Diabetes

September 29th 2023

Pharmacist-Led Interventions Can Improve HbA1c in Underserved Communities

September 29th 2023

Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric

July 6th 2023

Study Identifies Successful Strategies for Improving Diabetes Care Delivery

September 26th 2023

Tirzepatide Bests Semaglutide For A1c, Weight Loss in Indirect Comparison of Clinical Trial Data

September 25th 2023
© 2023 MJH Life Sciences

All rights reserved.